Reply to "CRISPR screens are feasible in TP53 wild-type cells".
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Haapaniemi, Emma
Botla, Sandeep https://orcid.org/0000-0001-9937-0455
Persson, Jenna
Schmierer, Bernhard https://orcid.org/0000-0002-9082-7022
Taipale, Jussi https://orcid.org/0000-0003-4204-0951
Abstract
Haapaniemi et al address the issues raised by Brown et al and discuss several differences between the analyses performed by the two groups.
Description
Keywords
CRISPR-Cas Systems, Clustered Regularly Interspaced Short Palindromic Repeats, DNA Damage, Gene Editing, Tumor Suppressor Protein p53
Journal Title
Mol Syst Biol
Conference Name
Journal ISSN
1744-4292
1744-4292
1744-4292
Volume Title
15
Publisher
Springer Science and Business Media LLC